KCT0000128已完成未知
A randomized, prospective, placebo-controlled double-blind, pilot study on the effect of Cilostazol for 4 weeks in patients with chronic tinnitus
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 90(Year)（—）
- 性别
- All
入选标准
- •Adults of age over 19
- •Unilateral or bilateral tinnitus
- •Chronic tinnitus lasting more than 3 months
- •Initial visual analogue scale of tinnitus >3
排除标准
- •Conductive hearing loss on pure tone audiometry
- •Associated other inner ear diseases such as Meniere’s disease
- •Objective or pulsatile tinnitus
- •Contraindication to anti-platelet drug
- •Any cardiac disease accompanying risk of thromboembolism
- •Bleeding tendency and major operation within 3 months
- •Breastfeeding
研究者
相似试验
已完成
3 期
A prospective, randomized, placebo-controlled, double-blind, cross-over study of the usefulness of sustained-release opioids in the subjective sensation of dyspnoea secondary to advanced disease with no reversible components in opioid naive patients.Opioids in Refractory dyspnoeaRespiratory - Other respiratory disorders / diseasesACTRN12607000075482Repatriation General Hospital48
进行中（未招募）
1 期
A clinical study to compare Toripalimab (JS001) combined with Lenvatinib versus placebo combined with Lenvatinib as the 1st-line therapy for advanced hepatocellular carcinoma (HCC)advanced hepatocellular carcinoma (HCC)EUCTR2020-004437-20-ITShanghai Junshi Biosciences Co., Ltd.519
进行中（未招募）
1 期
A clinical study to compare Toripalimab (JS001) combined with Lenvatinib versus placebo combined with Lenvatinib as the 1st-line therapy for advanced hepatocellular carcinoma (HCC)EUCTR2020-004437-20-PLShanghai Junshi Biosciences Co., Ltd519
进行中（未招募）
1 期
A prospective, randomised, placebo-controlled, double blind, multi-centre study of the effects of Irbesartan on aortic dilatation in Marfan syndromeMarfan SyndromeEUCTR2010-019302-16-GBRoyal Brompton and Harefield NHS Foundation Trust490
进行中（未招募）
1 期
A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin(R) in acute ischemic hemispehric stroke - CERE-LYSE-1EUCTR2004-001729-11-SKEBEWE Pharma GesmbH Nfg.KG